Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02783300 |
Title | Dose Escalation Study of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma (NHL) |
Acronym | Meteor 1 |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | GlaxoSmithKline |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | NLD | FRA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
GSK Investigational Site | Denver | Colorado | 80218 | United States | Details | |
GSK Investigational Site | Miami | Florida | 33136 | United States | Details | |
GSK Investigational Site | Middletown | New Jersey | 07748 | United States | Details | |
GSK Investigational Site | Harrison | New York | 10604 | United States | Details | |
GSK Investigational Site | New York | New York | 10065 | United States | Details | |
GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details | |
GSK Investigational Site | Dallas | Texas | 75230 | United States | Details | |
GSK Investigational Site | San Antonio | Texas | 78229 | United States | Details | |
GSK Investigational Site | Edmonton | Alberta | T6G 1Z2 | Canada | Details | |
GSK Investigational Site | Ottawa | Ontario | K1H 8L6 | Canada | Details | |
GSK Investigational Site | Toronto | Ontario | M5G 1Z5 | Canada | Details | |
GSK Investigational Site | Bordeaux Cedex | 33076 | France | Details | ||
GSK Investigational Site | Lyon Cedex 08 | 69373 | France | Details | ||
GSK Investigational Site | Villejuif cedex | 94805 | France | Details | ||
GSK Investigational Site | Amsterdam | 1066 CX | Netherlands | Details | ||
GSK Investigational Site | Leiden | 2333 ZA | Netherlands | Details | ||
GSK Investigational Site | Rotterdam | 3015 GD | Netherlands | Details |